XERS·98422E103·US·equity·Healthcare - Biotechnology-13D/G
XERS (XERIS BIOPHARMA HOLDINGS INC) is held by 121 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($75.1M), D. E. Shaw & Co., Inc. ($45.2M), STATE STREET CORP ($27M). Net institutional sentiment: Mixed.
See how XERS's score breaks down across 4 SEC sources
Showing 1-20 of 129
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer